Thursday, July 30

Browsing: SMARCA2

Research

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

By NewsCancerJuly 30, 20260

In this study, we provide a comprehensive clinicopathological, molecular, and tumor microenvironment (TME)-oriented characterization of SMARCA-deficient esophageal adenocarcinoma (EAC) in…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Merseyside lung cancer patient first in world to get new vaccine

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Browsing: SMARCA2

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Merseyside lung cancer patient first in world to get new vaccine

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Merseyside lung cancer patient first in world to get new vaccine

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Introduction to BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma

Latest Post

Merseyside lung cancer patient first in world to get new vaccine

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma

Relapsed childhood cancers show genomic scars left by previous therapy

Subscribe to Updates

What's Hot

Browsing: SMARCA2